SEC Form 4/A · accession 0001140361-17-038689
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
May 27, 2015
Accepted (ET)
Oct 13, 2017 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 27, 2015 | M | 34,078 | $67.81 | A | 109,663 | D | |
| Common StockF3,F2,F4 | May 27, 2015 | S | 34,078 | $130.00 | D | 75,585 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1,F2 | $67.81 | May 27, 2015 | M | 34,078 | D | Nov 15, 2013 | May 14, 2023 | Common Stock | 34,078 | 35,552 | D |
Explanation of responses
- F1On May 28, 2015, the reporting person filed a Form 4 which inadvertently failed to report this option exercise.
- F2Trade made pursuant to a 10b5-1 plan executed on March 11, 2015.
- F3On May 28, 2015, the reporting person filed a Form 4 which inadvertently reported an incorrect transaction date and deemed execution date. This amendment corrects such date.
- F4All shares sold at same price.